Susan Jane Severson, RN, BSN

Cystic Fibrosis Center - Research Nurse Clinician

Education

• St. Olaf College, Northfield, MN,Bachelor of Science in Nursing (BSN)

Professional Credentials

• University of Minnesota Medical School-Cystic Fibrosis Research Nurse Clinician
• University of Minnesota Hospital and Clinics, Staff Nurse
  Outpatient Clinics: Transplantation, Ophthalmology, Orthopedic, Pediatric
• University of Minnesota Medical School, Pediatric Neurology Resource Nurse
• University of Minnesota Hospital and Clinics, Head Nurse, Pediatric Clinic; Staff Nurse, Pediatrics (Toddlers)
• Fairview Hospital, Minneapolis Staff Nurse, Pediatrics

Areas of Interest

• Genotype/Phenotype, including nationality
• Congenital Absence of the Vas Deferens (CBAVD) in CF

Studies

• CF Foundation: Risk Factors in CF Decline
• Drug Research: (all multicenter national studies but one)
  • CPX ("gene assist")
  • TOBI (Tobramycin for Inhalation)
  • Pulmozyme: Phase Three
    • Phase Four
    • Sick Patients
    • Hospitalized Patients
    • Nebulizer
    • Epidemiologic: Use or Non-use of Pulmozyme
  • Early Intervention
  • Exosurf: efficacy
  • Pancrease: dosing and efficacy
  • Zymase: dosing and efficacy
  • Tobramycin vs Placebo in CF Exacerbation
• Genotype: CF center population
• Infant Antibiotic Prophylaxis in CF
• Glucose Intolerance in CF

Collaboration with Other CF Research Centers

• Denmark, Dr. K. Schmiegelow-blood samples for linkage studies
• Mayo Clinic, Rochester, MN-early haplotype/genotype
• University of Alabama, Birmingham, AL supplying CF trachea, nasal polyps Ray Frizzell, Ph.D.
• Howard Hughes Research Center-supplying nasal polyps - Michael J. Welsh, MD

Nursing Licensure: Minnesota

Publications: (some with former name Kujawa)

• Finkelstein SM, Budd JR, Ewing LB, Wielinski CL, Warwick WJ and Kujawa SJ. Data Quality Assurance for a Health Monitoring Program. Methods of Information in Medicine 24 (1985), 192-196.
• Finkelstein SM, Budd JR, Warwick WJ, Ewing LB, Kujawa SJ and Wielinski CL:Home monitoring in cystic fibrosis: a model program. Proceedings IEEE/Eng Med Biol Soc, 7:657-59, 1985.
• Finkelstein, SM, Budd JR, Warwick WJ, Kujawa SJ, Wielinski CL, Ewing LB: Feasibility and compliance studies of a home measurement monitoring program for cystic fibrosis. J Chron Dis Vol 39, No. 3, 1986, pp. 195-205.
• Finkelstein, SM, Kujawa SJ, Budd JR, Warwick WJ. An evaluation of incentive inspirometer for following pulmonary function by self-measurement in the home. IEEE Transactions on Biomedical Engineering BME-34, 3:212-216, 1987.
• Brown-Ewing L, Finkelstein SM, Budd JR, Kujawa SJ, Wielinski CL, Warwick WJ, Nguyen S: Implementation of a home-based program for early detection of clinical deterioration in cystic fibrosis. Medical Instrumentation, 22(5)240-6, 1988.
• Finkelstein SM, Wielinski CL, Kujawa SJ, Lowenson R, Warwick WJ: The impact of home monitoring and daily diary recording on patient status in cystic fibrosis. Pediatr Pulmonol, 12(1):3-10, 1992.

To contact Susan J. Severson, RN, BSN you can call the Pulmonary office at (612) 624-4440 or you can reach her by e-mail at:

sever003@maroon.tc.umn.edu

This page created on 2/9/1998

Last updated 2/19/98

Return to Peds PCCM home page